CTLA4Ig-gene transfection with FTY720 administration markedly inhibits the obliterative airway disease in heterotopically transplanted rat tracheas

Saved in:

Bibliographic Details
Published in:	Transplantation proceedings Vol. 35; no. 1; pp. 458 - 460
Main Authors:	Kita, Y, Li, X.-K, Nogimura, H, Ida, M, Kageyama, Y, Ohi, S, Suzuki, K, Kazui, T, Suzuki, S
Format:	Journal Article Conference Proceeding
Language:	English
Published:	New York, NY Elsevier Inc 01-02-2003 Elsevier Science
Subjects:	Abatacept Animals Biological and medical sciences Biotechnology Combined Modality Therapy Fingolimod Hydrochloride Fundamental and applied biological sciences. Psychology Gene therapy Health. Pharmaceutical industry Immunoconjugates - genetics Immunoconjugates - therapeutic use Immunomodulators Immunosuppressive Agents - therapeutic use Industrial applications and implications. Economical aspects Male Medical sciences Models, Animal Pharmacology. Drug treatments Postoperative Period Propylene Glycols - therapeutic use Rats Rats, Inbred Lew Rats, Inbred Strains Recombinant Proteins - therapeutic use Sphingosine - analogs & derivatives Time Factors Trachea - pathology Trachea - transplantation Transfection - methods Transplantation, Heterotopic Transplantation, Homologous - immunology Transplantation, Homologous - methods Transplantation, Homologous - pathology Rat Respiratory disease Treatment efficiency Rodentia Homograft Heterotopic Respiratory system Genetic transfer Respiratory tract Vertebrata Chemotherapy Mammalia Treatment Animal CTLA4Ig gene Bronchus disease Graft Bronchiolitis obliterans Combined treatment Immunosuppressive agent Fusion protein Trachea Hybrid gene
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0041-1345 1873-2623
DOI:	10.1016/S0041-1345(02)03977-5